- 全部删除
- 您的购物车当前为空
SARS-CoV-2-IN-14 是一种有效的、可口服的 SARS-CoV-2 抑制剂(IC50 :0.39 μM),是一种氯硝柳胺类似物。SARS-CoV-2-IN-14在人血浆和肝 S9 酶测定中比氯硝柳胺稳定性更强。SARS-CoV-2-IN-14以口服的方式给药可以提高其生物利用度和半衰期。
为众多的药物研发团队赋能,
让新药发现更简单!
SARS-CoV-2-IN-14 是一种有效的、可口服的 SARS-CoV-2 抑制剂(IC50 :0.39 μM),是一种氯硝柳胺类似物。SARS-CoV-2-IN-14在人血浆和肝 S9 酶测定中比氯硝柳胺稳定性更强。SARS-CoV-2-IN-14以口服的方式给药可以提高其生物利用度和半衰期。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 108 | In stock | |
5 mg | ¥ 221 | In stock | |
10 mg | ¥ 359 | In stock | |
25 mg | ¥ 648 | In stock | |
50 mg | ¥ 978 | In stock | |
100 mg | ¥ 1,450 | In stock | |
200 mg | ¥ 2,150 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 226 | In stock |
SARS-CoV-2-IN-14 相关产品
产品描述 | SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzyme. Oral administration of SARS-CoV-2-IN-14 can improve its bioavailability and half-life. |
靶点活性 | SARS-CoV-2:0.39 μM |
别名 | 3',5-Dichlorosalicylanilide |
分子量 | 282.12 |
分子式 | C13H9Cl2NO2 |
CAS No. | 22203-98-1 |
Smiles | C(NC1=CC(Cl)=CC=C1)(=O)C2=C(O)C=CC(Cl)=C2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 9 mg/mL (31.9 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容